Tumobos, Jonna .
HRN: 19-66-08 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/06/2024
CEFUROXIME 750MG (VIAL)
10/06/2024
10/12/2024
IVTT
335mg
Q8h
Urti
Waiting Final Action
Indication: Empiric Type of Infection: URTI Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes